Trademark Overview
On Monday, December 5, 2016, a trademark application was filed for ZYRUBIA with the United States Patent and Trademark Office. The USPTO has given the ZYRUBIA trademark a serial number of 87257519. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2017. This trademark is owned by Glaxo Group Limited. The ZYRUBIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain associated with rheumatoid arthritis, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines; all of the foregoing specifically excluding pharmaceutical preparations and substances acting on the central nervous system, pharmaceutical preparations and substances for the treatment and/or management of, sleep disorders, cognitive disorders, narcolepsy, and neurological or psychiatric diseases or disorders
